Post Type Archives: News

Bespak, the specialist inhalation contract development and manufacturing organisation (CDMO) today released its first Environmental, Social and Governance (ESG) update. This update provides an overview of Bespak’s actions and progress in key material topics across its value chain. It sets out its planned future steps as part of a holistic approach to sustainable operations. Evolving […]

SCHOTT Pharma, a pioneer in pharmaceutical storage and delivery solutions, is investing more than 100 million euros in its existing site in Lukácsháza, Hungary, to expand capacity for sterile ready-to-use (RTU) cartridges. Following the opening of a production facility for prefillable glass syringes in 2024, the company has now laid the foundation stone for another […]

Tjoapack, the global or a leading contract packaging organization (CPO) serving the pharmaceutical industry, has announced a significant expansion of its contract packaging and cold chain storage services in the United States and the Netherlands. Through these investments, Tjoapack is actively scaling its logistics infrastructure to meet the rising demand for injectable and biologic drug […]

EUROAPI, a European leader in the production of active pharmaceutical ingredients (API) and contract development and manufacturing organization (CDMO), is pleased to announce the appointment of Frédéric Robert to the newly created position of Chief Commercial Officer overseeing API Solutions and CDMO activities. He will join the company’s Executive Committee. This appointment is part of […]

CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce a strategic co-investment of more than CHF 25 million with a long-standing Japanese customer to expand manufacturing capabilities at its sites in Aarau and Neuland, Switzerland. The investment will support the production of a drug linker for […]

AGC Pharma Chemicals announces the appointment of Jun Kurihara as its new Chief Executive Officer, effective June 1, 2025. Kurihara, who currently serves as Executive Vice President, has extensive experience in the CDMO sector and has played a pivotal role in the company’s transformation and growth. In addition to his broad experience in the CDMO […]

Axplora, a global leader in API small molecule and ADC (antibody-drug conjugate) manufacturing, is proud to announce that its Chasse-sur-Rhône CDMO site in France has successfully passed its latest on-site inspection by the French National Agency for Medicines and Health Products Safety (ANSM). Conducted in February 2025, the inspection confirmed the site’s full compliance with […]

Almac Group, the global contract pharmaceutical development and manufacturing organisation, has today announced its highest ever revenue, profit and employee numbers. Figures released for Almac’s financial year ending 30 September 2024 reported £1.027 billion of revenues, a £69.5 million (7%) increase from 2023.  Pre-tax profits rose by 27% to £119 million, up from £93.8 million […]

TQ Therapeutics GmbH, a biotechnology company dedicated to advancing the field of cellular therapies through innovative technologies, today announced the acquisition of Juno Therapeutics GmbH (“Juno GmbH”), a cell therapy company, through a share purchase agreement. Juno GmbH is a German subsidiary of Juno Therapeutics, Inc., which is a wholly owned subsidiary of the global […]

Collaboration combines Nuclera’s eProtein Discovery System, which accelerates protein expression, purification and optimization, with Cytiva’s Biacore SPR system, which characterizes molecular interactions Collaboration allows researchers to progress rapidly from DNA to purified and characterized protein, to facilitate insights into drug-target interactions Showcased at Discovery on Target and PEGS Europe conferences, detailing the production and characterization […]